Document Detail


Poxvirus cancer therapy.
MedLine Citation:
PMID:  18221156     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Despite many advances in chemotherapy and other medical techniques, patients with cancer often develop local recurrence or metastatic spread. Recent advances in molecular biology and tumor immunology have led to the design of many new anti-tumor vaccines. Such approaches are now using recombinant viruses to treat different types of cancer. From these new developments, innovative fields are emerging: vaccine virotherapy, viral immunotherapy, oncolytic virotherapy and drug virotherapy. Many viruses are currently exploited as recombinant vectors and each offers natural or synthetic characteristics that may provide unique means to treat cancer. Poxviruses are large double stranded DNA viruses that offer many advantageous characteristics as recombinant vectors. Poxvirus-based vectors offer essentially unlimited possibilities for genetic manipulation due to the large size of their DNA and high degree of safety. Vaccinia virus, the prototype virus of the Orthopoxvirus genus that was extensively used to eradicate Smallpox, and other poxviruses are now being considered and used for the treatment of cancer. This review will cover their utilization as anti-cancer therapeutics by describing recent patents (2000-2005).
Authors:
Philippe-Alexandre Gilbert; Grant McFadden
Related Documents :
24552266 - [6]-gingerol as a cancer chemopreventive agent: a review of its activity on different s...
23419136 - Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of...
16033526 - Blood brothers: carbohydrates in xenotransplantation and cancer immunotherapy.
24016336 - Appalachian women's perspectives on breast and cervical cancer screening.
24040396 - Association between the rad51 135 g>c polymorphism and risk of cancer: a meta-analysis ...
16117016 - Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Recent patents on anti-infective drug discovery     Volume:  1     ISSN:  1574-891X     ISO Abbreviation:  -     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2008-01-28     Completed Date:  2008-02-21     Revised Date:  2009-01-22    
Medline Journal Info:
Nlm Unique ID:  101266084     Medline TA:  Recent Pat Antiinfect Drug Discov     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  309-21     Citation Subset:  IM    
Affiliation:
Robarts Research Institute, BioTherapeutics Research Group, Siebens-Drake Building Room 133, 1400 Western Road, London, Ontario, Canada N6G 2V4.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Neoplasm / immunology
Cancer Vaccines*
Genetic Vectors
Humans
Neoplasms / immunology,  therapy*
Poxviridae / genetics*,  immunology
Chemical
Reg. No./Substance:
0/Antigens, Neoplasm; 0/Cancer Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SARS coronavirus anti-infectives.
Next Document:  Recent patents on nucleoside and nucleotide inhibitors for HCV.